Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1819 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

MannKind Updates On NDA For Afrezza

Reportedly, the FDA has not yet completed its inspection of the insulin manufacturing facilities of NV Organon, a third-party supplier to MannKind. Organon is a subsidiary of Merck.

Svelte Initiates European Clinical Trial For SOAW

The company also plans to introduce its drug eluting stent (DES) with non-inflammatory properties instead of utilising typical polymeric coatings, which are known to irritate the vessel lining.

Lundbeck, Teva Launch Azilect In France

Stig Pedersen, executive vice president of commercial operations at Lundbeck, said: “The reimbursement of Azilect is of great importance to the many patients in France suffering from parkinson’s